Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-RAD LABORATORIES, INC. Director's Dealing 2017

May 12, 2017

30786_dirs_2017-05-11_92cdd6e1-e4e1-4435-8a91-f1c425b49106.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO RAD LABORATORIES INC (BIO, BIOB)
CIK: 0000012208
Period of Report: 2017-05-10

Reporting Person: GOETZ JOHN (EVP, Chief Operating Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-05-10 Bio-Rad A Common Stock M 3500 $74.27 Acquired 61470.1596 Direct
2017-05-10 Bio-Rad A Common Stock F 2271 $223.00 Disposed 59199.1596 Direct
2017-05-10 Bio-Rad A Common Stock M 3500 $84.57 Acquired 62699.1596 Direct
2017-05-10 Bio-Rad A Common Stock F 2462 $223.00 Disposed 60237.1596 Direct
2017-05-10 Bio-Rad A Common Stock M 3500 $98.04 Acquired 63737.1596 Direct
2017-05-10 Bio-Rad A Common Stock F 2563 $223.00 Disposed 61174.1596 Direct
2017-05-11 Bio-Rad A Common Stock M 3500 $88.00 Acquired 64674.1596 Direct
2017-05-11 Bio-Rad A Common Stock S 3500 $220.1686 Disposed 61174.1596 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-05-10 Non-Qualified Stock Option (right to buy) $74.27 M 3500 Disposed 2019-06-10 Bio-Rad A Common Stock (3500) Direct
2017-05-10 Non-Qualified Stock Option (right to buy) $84.57 M 3500 Disposed 2020-09-08 Bio-Rad A Common Stock (3500) Direct
2017-05-10 Non-Qualified Stock Option (right to buy) $98.04 M 3500 Disposed 2021-11-04 Bio-Rad A Common Stock (3500) Direct
2017-05-11 Non-Qualified Stock Option (right to buy) $88.00 M 3500 Disposed 2018-06-11 Bio-Rad A Common Stock (3500) Direct

Footnotes

F1: Includes 47.7598 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 03/31/2017.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $220.00 to $220.35 inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securites and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3: The option vested in five equal annual installments beginning on June 10, 2010.

F4: The option vested in five equal annual installments beginning on September 8, 2011.

F5: The option vested in five equal annual installments beginning on November 4, 2012.

F6: The option vested in five equal annual installments beginning on June 11, 2009.